SCHEDULE: Federated Hermes Discloses Minerva Neurosciences Stake

Federated Hermes, Inc. and associated entities have filed a Schedule 13G, reporting beneficial ownership of 17.17% of Minerva Neurosciences, Inc. common stock as of June 30, 2026.

Summary

• Federated Hermes, Inc., along with the Voting Shares Irrevocable Trust, Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue, have jointly filed a Schedule 13G.
• This filing indicates beneficial ownership of 8,690,926 shares of Minerva Neurosciences, Inc. common stock.
• This represents 17.17% of the total class of securities.
• The filing is an amendment, with the event date requiring the filing being June 30, 2026.
• Federated Hermes, Inc. is identified as a parent holding company, and the Voting Shares Irrevocable Trust holds all of its voting stock.
• The Donahue individuals act as trustees for the Voting Shares Irrevocable Trust and have jointly filed due to their collective voting control over Federated Hermes, Inc.
• All parties disclaim beneficial ownership of the securities held by managed funds, stating the filing should not be construed as an admission of beneficial ownership.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It provides transparency on a significant ownership stake but lacks operational or financial details about the company itself, offering no clear positive or negative indicators for investors.

Positives

• Significant stake reported by a major financial entity, potentially indicating confidence or strategic interest in Minerva Neurosciences.
• Clear disclosure of beneficial ownership and percentage, providing transparency to the market.

Negatives

• The filing does not contain financial performance data for Minerva Neurosciences, Inc., making it difficult to assess the company's operational health.
• The disclaimer of beneficial ownership by Federated Hermes and associated individuals may suggest a passive investment rather than active control or strategic partnership.

Risks

• The filing does not detail specific risks related to Minerva Neurosciences, Inc.'s business operations or future prospects.
• Potential for future changes in beneficial ownership, which could impact share price and market dynamics.

Future Outlook

The filing does not contain any forward-looking statements or guidance from Minerva Neurosciences, Inc. It solely reports on beneficial ownership.

Management Comments

• In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically indicate passive investment stakes by institutional investors. The significant percentage held by Federated Hermes suggests a notable position, but the disclaimers imply it's not an activist stake aimed at control.

Stakeholder Impact

• Shareholders gain clarity on a significant beneficial owner, potentially influencing market perception.
• Management of Minerva Neurosciences, Inc. is aware of a substantial passive stake, which may inform strategic discussions.
• Creditors and other stakeholders receive information that contributes to the overall understanding of the company's ownership structure.

Next Steps

• Monitor future filings from Federated Hermes, Inc. and other significant shareholders for any changes in ownership or investment strategy.
• Review Minerva Neurosciences, Inc.'s own SEC filings for operational updates, financial performance, and strategic developments.

Key Dates

Keywords

Schedule 13G, Minerva Neurosciences, Federated Hermes, Beneficial Ownership, Common Stock, SEC Filing, Investment Management, Shareholder